Trial Profile
An Open-Label Study to Determine ADME of 14C Labeled SLV337 After a Single Dose of an Oral Suspension.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2011
Price :
$35
*
At a glance
- Drugs SLV 337 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 21 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Dec 2010 Actual end date (October 2010) added as reported by ClinicalTrials.gov.
- 28 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.